Botanical species · safety record

Celosia argentea

The EFSA Compendium of Botanicals holds 9 constituent measurements and 2 adverse-effect records for Celosia argentea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Celosia argentea L.

9Constituent measurements

2Safety records

5Cited sources

2Licensed products (Canada)

Also recorded as

CEOAR

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 2 licensed products naming Celosia argentea as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Seed(s)

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
4-hydroxybenzaldehyde	Leaves	Solvent extraction	—	HPLC with standard detection methods	Resolve DOI
Betalains	Flowering top	Solvent extraction	≤ 0.0622 Millimol/100 Gramm	HPLC with standard detection methods	Resolve DOI
Betalains	Flowering top	Solvent extraction	≥ 0.0092 Millimol/100 Gramm	HPLC with standard detection methods	Resolve DOI
Calcium oxalate	Leaves	—	—	Microscopic detection	Resolve DOI
Dopamine	Flowering top	Solvent extraction	—	HPLC with standard detection methods	Resolve DOI
Gallic acid	Leaves	Solvent extraction	—	HPLC with standard detection methods	Resolve DOI
P-coumaric acid	Leaves	Solvent extraction	—	HPLC with standard detection methods	Resolve DOI
Oxalic acid	Leaves	Powder	≥ 9.5 Percent	Unspecified	No resolvable identifier
Oxalic acid	Leaves	Powder	≤ 12 Percent	Unspecified	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Unspecified	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive	Unspecified	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Oke, O. L. Chemical changes in some Nigerian vegetables during growth. Experimental Agriculture, 1968, p. 345-349.
Perveen, Shagufta., Yousaf, Muhammad., Zahoor, Ameer Fawad., Rasool, Nasir., Jabber, Abdul. Extraction, isolation, and identification of various environment friendly components from cock's comb (Celosia argentea) leaves for allelopathic potential. TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY, 2014, vol. 96, no. 10, p. 1523-1534. DOI
Schliemann, W., Cai, YZ., Degenkolb, T., Schmidt, J., Corke, H. Betalains of Celosia argentea. PHYTOCHEMISTRY, 2001, vol. 58, no. 1, p. 159-165. DOI
Ghorpade, P., Siddiqui, A., Patil, M.J., Rub, R.A. Pharmacognostic and phytochemical evaluation of Celosia argentea. Pharmacognosy Journal, 2012, vol. 4, no. 33, p. 7-15. DOI
Telagari, Madhusudhan., Hullatti, Kirankumar. In-vitro alpha-amylase and alpha-glucosidase inhibitory activity of Adiantum caudatum Linn. and Celosia argentea Linn. extracts and fractions . Indian journal of pharmacology, 2015, vol. 47, no. 4, p. 425-429. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature